Remus Pharmaceuticals Limited — Others, 14-07-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Remus Pharmaceuticals has announced that it is exempt from submitting certain corporate governance reports. The company's listing on the National Stock Exchange's SME Emerge Platform provides it with this exemption. As a result, Remus is not required to file quarterly, half-yearly, or annual Corporate Governance Reports. This clarification is important for shareholders as it explains why these specific disclosure documents will not be publicly available from the company, aligning its compliance obligations with its SME listing status. This update helps investors understand the company's reporting framework.